1265 related articles for article (PubMed ID: 23334791)
21. NK cells and type 1 innate lymphoid cells: partners in host defense.
Spits H; Bernink JH; Lanier L
Nat Immunol; 2016 Jun; 17(7):758-64. PubMed ID: 27328005
[TBL] [Abstract][Full Text] [Related]
22. TCF-1 controls ILC2 and NKp46+RORγt+ innate lymphocyte differentiation and protection in intestinal inflammation.
Mielke LA; Groom JR; Rankin LC; Seillet C; Masson F; Putoczki T; Belz GT
J Immunol; 2013 Oct; 191(8):4383-91. PubMed ID: 24038093
[TBL] [Abstract][Full Text] [Related]
23. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation.
Takedatsu H; Michelsen KS; Wei B; Landers CJ; Thomas LS; Dhall D; Braun J; Targan SR
Gastroenterology; 2008 Aug; 135(2):552-67. PubMed ID: 18598698
[TBL] [Abstract][Full Text] [Related]
24. Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.
Qiu J; Zhou L
Semin Immunopathol; 2013 Nov; 35(6):657-70. PubMed ID: 23975386
[TBL] [Abstract][Full Text] [Related]
25. Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.
Cella M; Gamini R; Sécca C; Collins PL; Zhao S; Peng V; Robinette ML; Schettini J; Zaitsev K; Gordon W; Bando JK; Yomogida K; Cortez V; Fronick C; Fulton R; Lin LL; Gilfillan S; Flavell RA; Shan L; Artyomov MN; Bowman M; Oltz EM; Jelinsky SA; Colonna M
Nat Immunol; 2019 Aug; 20(8):980-991. PubMed ID: 31209406
[TBL] [Abstract][Full Text] [Related]
26. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
27. Lineage relationship analysis of RORgammat+ innate lymphoid cells.
Sawa S; Cherrier M; Lochner M; Satoh-Takayama N; Fehling HJ; Langa F; Di Santo JP; Eberl G
Science; 2010 Oct; 330(6004):665-9. PubMed ID: 20929731
[TBL] [Abstract][Full Text] [Related]
28. Dissecting human ILC heterogeneity: more than just three subsets.
Simoni Y; Newell EW
Immunology; 2018 Mar; 153(3):297-303. PubMed ID: 29140572
[TBL] [Abstract][Full Text] [Related]
29. Fingolimod Alters Tissue Distribution and Cytokine Production of Human and Murine Innate Lymphoid Cells.
Eken A; Yetkin MF; Vural A; Okus FZ; Erdem S; Azizoglu ZB; Haliloglu Y; Cakir M; Turkoglu EM; Kilic O; Kara I; Dönmez Altuntaş H; Oukka M; Kutuk MS; Mirza M; Canatan H
Front Immunol; 2019; 10():217. PubMed ID: 30828332
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
[TBL] [Abstract][Full Text] [Related]
31. Runx3 specifies lineage commitment of innate lymphoid cells.
Ebihara T; Song C; Ryu SH; Plougastel-Douglas B; Yang L; Levanon D; Groner Y; Bern MD; Stappenbeck TS; Colonna M; Egawa T; Yokoyama WM
Nat Immunol; 2015 Nov; 16(11):1124-33. PubMed ID: 26414766
[TBL] [Abstract][Full Text] [Related]
32. Enrichment of IL-17A
Li J; Doty AL; Tang Y; Berrie D; Iqbal A; Tan SA; Clare-Salzler MJ; Wallet SM; Glover SC
Clin Exp Immunol; 2017 Oct; 190(1):143-153. PubMed ID: 28586085
[TBL] [Abstract][Full Text] [Related]
33. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic.
Ferlazzo G; Thomas D; Lin SL; Goodman K; Morandi B; Muller WA; Moretta A; Münz C
J Immunol; 2004 Feb; 172(3):1455-62. PubMed ID: 14734722
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
[TBL] [Abstract][Full Text] [Related]
35. Functional and phenotypic heterogeneity of group 3 innate lymphoid cells.
Melo-Gonzalez F; Hepworth MR
Immunology; 2017 Mar; 150(3):265-275. PubMed ID: 27935637
[TBL] [Abstract][Full Text] [Related]
36. Diversity and function of group 1 innate lymphoid cells.
Cortez VS; Colonna M
Immunol Lett; 2016 Nov; 179():19-24. PubMed ID: 27394699
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs.
Silver JS; Kearley J; Copenhaver AM; Sanden C; Mori M; Yu L; Pritchard GH; Berlin AA; Hunter CA; Bowler R; Erjefalt JS; Kolbeck R; Humbles AA
Nat Immunol; 2016 Jun; 17(6):626-35. PubMed ID: 27111143
[TBL] [Abstract][Full Text] [Related]
38. NCR
Mikami Y; Scarno G; Zitti B; Shih HY; Kanno Y; Santoni A; O'Shea JJ; Sciumè G
Eur J Immunol; 2018 Jul; 48(7):1174-1180. PubMed ID: 29524223
[TBL] [Abstract][Full Text] [Related]
39. The early expansion of anergic NKG2A
Roberto A; Di Vito C; Zaghi E; Mazza EMC; Capucetti A; Calvi M; Tentorio P; Zanon V; Sarina B; Mariotti J; Bramanti S; Tenedini E; Tagliafico E; Bicciato S; Santoro A; Roederer M; Marcenaro E; Castagna L; Lugli E; Mavilio D
Haematologica; 2018 Aug; 103(8):1390-1402. PubMed ID: 29700172
[TBL] [Abstract][Full Text] [Related]
40. CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.
Salomé B; Gomez-Cadena A; Loyon R; Suffiotti M; Salvestrini V; Wyss T; Vanoni G; Ruan DF; Rossi M; Tozzo A; Tentorio P; Bruni E; Riether C; Jacobsen EM; Jandus P; Conrad C; Hoenig M; Schulz A; Michaud K; Della Porta MG; Salvatore S; Ho PC; Gfeller D; Ochsenbein A; Mavilio D; Curti A; Marcenaro E; Steinle A; Horowitz A; Romero P; Trabanelli S; Jandus C
Blood Adv; 2019 Nov; 3(22):3674-3687. PubMed ID: 31765481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
